Daratumumab monotherapy in heavily pretreated Asians patients with relapsed and refractory multiple myeloma

被引：0
|
作者：
Yoon, Sung-Soo [1 ]
Byun, Ja Min [1 ]
Park, Hyunkyung [2 ]
Lee, Ji Yun [3 ]
Koh, Youngil [1 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul, South Korea
[2] Seoul Natl Univ, Boramae Med Ctr, Seoul, South Korea
[3] Seoul Natl Univ, Bundang Hosp, Seoul, South Korea
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期
关键词：
Asia; daratumumab; real-world evidence;
D O I：
10.1016/j.clml.2019.09.259
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
FP-174
引用
收藏
页码：E155 / E156
页数：2
相关论文
共 50 条
  • [31] Dose-dependent efficacy of daratumumab (DARA) as monotherapy in patients with relapsed or refractory multiple myeloma (RR MM).
    Lokhorst, Henk M.
    Laubach, Jacob
    Nahi, Hareth
    Plesner, Torben
    Gimsing, Peter
    Hansson, Markus
    Minnema, Monique
    Lassen, Ulrik Niels
    Krejcik, Jakub
    Ahmadi, Tahamtan
    Lisby, Steen
    Basse, Linda
    Brun, Nikolai C.
    Richardson, Paul G.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] Daratumumab monotherapy in relapsed and refractory multiple myeloma patients with severely compromised forced expiratory volume in one second
    Kim, Jin-Hyo
    Park, Sung-Soo
    Yoon, Jae-Ho
    Lee, Sung-Eun
    Kim, Hee-Je
    Min, Chang-Ki
    BLOOD RESEARCH, 2022, 57 (01) : 76 - 80
  • [33] EFFECTIVENESS AND SAFETY ANALYSIS OF DARATUMUMAB IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Kumar, Seri A.
    Fe, Bitaube R.
    Hinojosa, Orantos C.
    Gavira, Moreno R.
    Garzon, Lopez S.
    HAEMATOLOGICA, 2021, 106 (10) : 339 - 340
  • [34] Daratumumab monotherapy for relapsed/refractory multiple myeloma, focussed on clinical trial-unfit patients and subsequent therapy
    Park, Sung-Soo
    Byun, Ja Min
    Yoon, Sung-Soo
    Kim, Kihyun
    Jung, Sung-Hoon
    Lee, Je-Jung
    Min, Chang-Ki
    BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (01) : 101 - 112
  • [35] Results of the daratumumab monotherapy early access treatment protocol in patients from Brazil with relapsed or refractory multiple myeloma
    Crusoe, Edvan de Queiroz
    Fernandes Pimenta, Flavia Cristina
    Maiolino, Angelo
    de Castro, Nelson Siqueira
    Pei, Huiling
    Trufelli, Damila
    Fernandez, Mariana
    Herriot, Luciana Barreto
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2021, 43 (04) : 417 - 423
  • [36] Subcutaneous delivery of daratumumab in Japanese patients with relapsed/refractory multiple myeloma
    Shibayama, Hirohiko
    Matsumoto, Morio
    Kosugi, Hiroshi
    Shibayama, Kazuhiro
    Yamazaki, Hiroshi
    Iida, Shinsuke
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2021, 113 (01) : 112 - 121
  • [37] Daratumumab plus carfilzomib and dexamethasone in patients with relapsed or refractory multiple myeloma
    Chari, Ajai
    Martinez-Lopez, Joaquin
    Mateos, Maria-Victoria
    Blade, Joan
    Benboubker, Lotfi
    Oriol, Albert
    Arnulf, Bertrand
    Rodriguez-Otero, Paula
    Pineiro, Luis
    Jakubowiak, Andrzej
    de Boer, Carla
    Wang, Jianping
    Clemens, Pamela L.
    Ukropec, Jon
    Schecter, Jordan
    Lonial, Sagar
    Moreau, Philippe
    BLOOD, 2019, 134 (05) : 421 - 431
  • [38] DOSE-DEPENDENT EFFICACY OF DARATUMUMAB (DARA) AS MONOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RR MM)
    Lokhorst, H.
    Laubach, J.
    Nahi, H.
    Plesner, T.
    Gimsing, P.
    Hansson, M.
    Minnema, M.
    Lassen, U.
    Krejcik, J.
    Ahmadi, T.
    Khan, I.
    Uhlar, C.
    Lisby, S.
    Basse, L.
    Brun, N.
    Richardson, P.
    HAEMATOLOGICA, 2014, 99 : 106 - 107
  • [39] Selinexor, daratumumab, and dexamethasone in patients with relapsed/refractory multiple myeloma (MM).
    Gasparetto, Cristina
    Lentzsch, Suzanne
    Schiller, Gary J.
    Callander, Natalie Scott
    Tuchman, Sascha
    Bahlis, Nizar J.
    White, Darrell
    Chen, Christine
    Baljevic, Muhamed
    Sutherland, Heather J.
    Kotb, Rami
    Sebag, Michael
    LeBlanc, Richard
    Venner, Christopher P.
    Bensinger, William
    Rossi, Adriana C.
    Sheehan, Heidi
    Arazy, Melina
    Kai, Kazuharu
    Lipe, Brea
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [40] Subcutaneous delivery of daratumumab in Japanese patients with relapsed/refractory multiple myeloma
    Hirohiko Shibayama
    Morio Matsumoto
    Hiroshi Kosugi
    Kazuhiro Shibayama
    Hiroshi Yamazaki
    Shinsuke Iida
    International Journal of Hematology, 2021, 113 : 112 - 121
12345